Remote CGM monitoring may improve glycemic outcomes
Study showed patients in urban, under-resourced setting were significantly more likely to achieve target HbA1c.
April 29, 2026
By
Henry Thomas
2 min read
Clinical Scorecard: Remote monitoring with CGM may improve glycemic outcomes in urban, underserved diabetic population
At a Glance
Category Detail
Condition Type 2 Diabetes Mellitus (T2DM) Key Mechanisms Remote patient monitoring (RPM) using continuous glucose monitoring (CGM) Target Population Adults with type 2 diabetes and HbA1c > 8.5% Care Setting Safety-net hospital
Key Highlights
RPM participants had a greater reduction in HbA1c (3.0% vs. 2.1%) compared to controls. 60% of RPM participants achieved HbA1c < 7.5% versus 36% of controls. Adjusted odds ratio for achieving glycemic targets in RPM group was 2.53. Study highlights effectiveness of RPM and CGM in urban, under-resourced settings. Further studies needed for larger scale implementation. Guideline-Based Recommendations
Diagnosis
Evaluate HbA1c levels in adults with type 2 diabetes. Management
Consider RPM with CGM for patients with HbA1c > 8.5%. Monitoring & Follow-up
Conduct monthly telemedicine visits with endocrinology specialists. Risks
Potential need for medication adjustments, including insulin and GLP-1 receptor agonists. Patient & Prescribing Data
Adults with type 2 diabetes receiving care at a safety-net hospital.
Medication adjustments commonly involved insulin and GLP-1 receptor agonists.
Clinical Best Practices
Implement RPM programs in urban, underserved populations to improve glycemic control. Utilize CGM for continuous monitoring of glucose levels. References
AACE Endocrine AI
is published by Conexiant under a license arrangement with the American Association of Clinical Endocrinology, Inc. (AACE ® ). The ideas and opinions expressed in
AACE Endocrine AI do not necessarily reflect those of Conexiant or AACE. For more information, see Policies .